LIVN

Featured Pick

LivaNova PLC

Real picks. Real tracking. We bet on one stock daily and show you exactly how it plays out.

Jan 30, 2026

AI Confidence Score

Entry Price

$65.71

Current Price

$40.56

Total Return

+0.00%

vs SPY

+0.00%

As of Close 2026-01-30

Executive Summary

LivaNova (LIVN) has secured a transformative regulatory win as CMS confirms a ~48% reimbursement boost for its VNS Therapy effective 2026, fundamentally re-rating the stock's revenue quality. This idiosyncratic catalyst has triggered an 'Alpha Male' breakout to fresh 52-week highs, drawing institutional capital seeking defensive growth amidst the broader market's pre-earnings anxiety.

Technical Context

Setup

The breakout is validated by 1.9x average volume and a clean move above resistance, confirming strong accumulation at the highs.

Invalidation (Stop)

A daily close below the $60.64 breakout support level would invalidate the immediate momentum setup.

Runner-ups

BEN— Superior technicals (Score 13.0, Vol 4.4x) but lacks a specific news catalyst to anchor the move

RGLD— Strong fundamental guidance (+50% earnings growth) but weak technical score (4.0) suggests lagging momentum

Recent Performance History

5 Total Picks • 50% Win Rate (7d)

Date	Ticker	Entry	Last	Gain/Loss	7d	30d	60d
2026-01-27	BPOP	$130.60	$133.53	+2.24%	N/A	N/A	N/A
2026-01-26	ZM	$95.46	$92.10	-3.52%	N/A	N/A	N/A
2026-01-23	ERIC	$10.43	$10.80	+3.55%	+3.55%	N/A	N/A
2026-01-22	TCBX	$42.33	$40.56	-4.18%	-4.18%	N/A	N/A

← Back to Dashboard View LIVN Details →

Schema v1.0 | Pipeline v1.2.0